JP2024514090A5 - - Google Patents
Info
- Publication number
- JP2024514090A5 JP2024514090A5 JP2023560010A JP2023560010A JP2024514090A5 JP 2024514090 A5 JP2024514090 A5 JP 2024514090A5 JP 2023560010 A JP2023560010 A JP 2023560010A JP 2023560010 A JP2023560010 A JP 2023560010A JP 2024514090 A5 JP2024514090 A5 JP 2024514090A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- cyclopropanecarboxamide
- triazole
- carboxamide
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163167504P | 2021-03-29 | 2021-03-29 | |
| US63/167,504 | 2021-03-29 | ||
| PCT/US2022/021815 WO2022212181A1 (en) | 2021-03-29 | 2022-03-24 | Crystal forms of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d3)pyridazine-3-carboxamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514090A JP2024514090A (ja) | 2024-03-28 |
| JP2024514090A5 true JP2024514090A5 (cg-RX-API-DMAC10.html) | 2025-04-01 |
Family
ID=81308277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560010A Pending JP2024514090A (ja) | 2021-03-29 | 2022-03-24 | 6-(シクロプロパンカルボキサミド)-4-((2-メトキシ-3-(1-メチル-1h-1,2,4-トリアゾール-3-イル)フェニル)アミノ)-n-(メチル-d3)ピリダジン-3-カルボキサミドの結晶形態 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240190845A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4313974A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024514090A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230163469A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117377667A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022212181A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3601268T (lt) * | 2017-03-30 | 2021-05-25 | Bristol-Myers Squibb Company | 6-(ciklopropanamido)-4-((2-metoksi-3-(1-metil-1h-1,2,4-triazol-3-il)fenil)amino)-n-(metil-d3)piridazino-3-karboksamido gavimo būdas |
| JP2024529763A (ja) * | 2021-08-20 | 2024-08-08 | ブリストル-マイヤーズ スクイブ カンパニー | 6-(シクロプロパンカルボキサミド)-4-((2-メトキシ-3-(1-メチル-1h-1,2,4-トリアゾール-3-イル)フェニル)アミノ)-n-(メチル-d3)ピリダジン-3-カルボキサミドの結晶体 |
| EP4713315A1 (en) * | 2023-05-15 | 2026-03-25 | Alivus Life Sciences Limited | Process for the preparation of deucravacitinib, and crystalline forms thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20220766T1 (hr) * | 2012-11-08 | 2022-09-16 | Bristol-Myers Squibb Company | Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora |
| LT3601268T (lt) * | 2017-03-30 | 2021-05-25 | Bristol-Myers Squibb Company | 6-(ciklopropanamido)-4-((2-metoksi-3-(1-metil-1h-1,2,4-triazol-3-il)fenil)amino)-n-(metil-d3)piridazino-3-karboksamido gavimo būdas |
| CN111032646B (zh) * | 2017-08-01 | 2023-01-03 | 施万生物制药研发Ip有限责任公司 | 作为jak激酶抑制剂的吡唑并和三唑并双环化合物 |
| CN118994118A (zh) * | 2018-05-31 | 2024-11-22 | 百时美施贵宝公司 | 化合物的结晶形式 |
| US11357775B2 (en) * | 2019-04-30 | 2022-06-14 | Celgene Corporation | Combination therapies comprising apremilast and Tyk2 inhibitors |
| US12570637B2 (en) * | 2019-06-12 | 2026-03-10 | Bristol-Myers Squibb Company | Crystalline salt forms 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyld3) pyridazine-3-carboxamide |
| CN114787152A (zh) * | 2019-12-27 | 2022-07-22 | 苏州科睿思制药有限公司 | 一种bms-986165晶型及其制备方法和用途 |
-
2022
- 2022-03-24 CN CN202280036814.3A patent/CN117377667A/zh active Pending
- 2022-03-24 WO PCT/US2022/021815 patent/WO2022212181A1/en not_active Ceased
- 2022-03-24 US US18/284,531 patent/US20240190845A1/en active Pending
- 2022-03-24 EP EP22716694.9A patent/EP4313974A1/en active Pending
- 2022-03-24 KR KR1020237036640A patent/KR20230163469A/ko active Pending
- 2022-03-24 JP JP2023560010A patent/JP2024514090A/ja active Pending